SCHEMBL30470710

SCHEMBL30470710

CNc1cccc([C@@H]2CCCCN2C(=O)C(=O)Nc2cncc(C(N)=O)c2)c1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 0.62
▸ WDR77 Q9BQA1 10/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29981438 1.00 PRMT5 (0.62) PRMT5WDR77
SCHEMBL24367343 1.00 PRMT5 (0.62) PRMT5WDR77
SCHEMBL24364023 1.00 PRMT5 (0.62) PRMT5WDR77
SCHEMBL24365355 1.00 PRMT5 (0.62) PRMT5WDR77
SCHEMBL24364742 0.91 PRMT5 (0.63) PRMT5WDR77
SCHEMBL24363916 0.90 PRMT5 (0.62) PRMT5WDR77
SCHEMBL24365418 0.89 PRMT5 (0.61) PRMT5WDR77
SCHEMBL24363936 0.89 PRMT5 (0.74) PRMT5WDR77
SCHEMBL24365207 0.89 PRMT5 (0.74) PRMT5WDR77
SCHEMBL24365573 0.89 PRMT5 (0.74) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4188920-A1 PIPERIDIN-1-YL-N-PYRYDINE-3-YL-2-OXOACETAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF MTAP-DEFICIENT AND/OR MTA-ACCUMULATING CANCERS Tango Therapeutics, Inc. (US) 2023-06-07 — — EP disclosed
Send feedback